SOPHiA GENETICS Reports Strong Q4 and 2025 Results, Announces 2026 Growth Guidance SOPHiA GENETICS shares its preliminary financial results for Q4 and 2025, revealing robust growth and a new CEO appointment for 2026.

SOPHiA GENETICS Reports Strong Q4 and 2025 Results, Announces 2026 Growth Guidance #USA #Boston #SOPHiA_GENETICS #AI_Precision_Medicine #Jurgi_Camblong

SOPHiA GENETICS Reports Preliminary Q4 2025 Financial Results and Management Changes SOPHiA GENETICS announces strong preliminary financial results for Q4 2025, forecasts for 2026 growth, and CEO transition plans. Discover the insights.

SOPHiA GENETICS Reports Preliminary Q4 2025 Financial Results and Management Changes #USA #Boston #financial_results #SOPHiA_GENETICS #AI_Precision_Medicine